TSE:MFC

Manulife Financial (MFC.TO)

54.00
+0.50 (0.93%)
as of Jun 5, 2026, 8:00:00 pm Market Open.
1636 watching
0
Investor Insights
star iconJun 5, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) is viewed positively by several analysts, who note its solid growth in Asia and the wealth management sector. The company is seen as a stable and reliable option, with a decent dividend yield that appeals to income-focused investors. Analysts acknowledge that while MFC has experienced some recent challenges, especially in its U.S. operations and corrections after strong performances, it maintains a healthy growth outlook. Concerns about the overall market and macroeconomic factors have led to suggestions of caution, but many believe MFC's valuation is still attractive relative to its peers, particularly the banks. In the long term, it remains a compelling investment opportunity with the potential for growth, other factors such as credit risk being minimal.

consensus icon
Consensus
Positive
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
WATCH
Buy lifecos or banks? This sell-off has been peculiar, because the most-damaged are value stocks including financials in Canada and the U.S. Massacred. MFC is close to a low. It has huge upside potential based on its earnings. But they're in medical insurance. He suspects these stocks are getting close to attractive prices.
DON'T BUY

He would wait for now and would prefer SLF-T. Insurance companies can't benefit from lowering interest rates.

WAIT
Nov-Apr is seasonality. Even before today's sell-off there was trouble brewing in this. This looks like it's heading to its Dec. 2018 chart. In each rebound up MFC will see shareholders sell into strength. That's a warning. Wait on this one.
HOLD
Exposure to China? He owns a position on behalf of clients. He thinks the share drop is manageable. With a life insurance company, there is always a need to have it. Demand may be delayed and deferred, but not lost. You can hold it here. Longer term there is more upside than downside. Lower interest rates do hurt their longer term exposures, but he expects 10 year interest rates to return to normal going forward. Yield 5%
BUY
How can MFC maintain its upward trajectory after the central banks cut interest rates? Insurers have been hit hard by the low rates, including MFC, but it will eventually reach $30, because it's very profitable, has strong Asian growth from its growing middle class, and is performing well in North America. Buy/own this, put it away and forget it for five years. By then, it'll reach $30.
DON'T BUY
It is only trading 6 times earnings. However, the interest rate environment makes it difficult for life insurance companies going forward. They have done a good job growing their business in Asia. He just sees better opportunities.
COMMENT

Chart shows a double-top of $27. Insurance looks good. Nice upward move since start-2019 in MFC. He doesn't know the fundamentals of MFC, though it got hit hard today in the global sell-off. He owns other insurers including Sun-Life.

DON'T BUY
They're definitely in China, but he doesn't know their exposure now. The really challenge is an aging population and a system that doesn't manage chronic diseases well. Be careful with Manulife, but also all insurers.
COMMENT
He stills likes Sun Life better. He's concerned about the emphasis that Manulife has put on Far Eastern growth they anticipate. Manulife has a checkered history of surprising on the down-side, whereas Sun Life is more predictable. Sun Life has good presence in North America.
TOP PICK
The Canadian stock market has massively under-performed the US for the last decade. MFC-T has under-performed the insurance sector and recovered from all of its miss-steps. It is trading at 10 times earnings, with share buy-backs and debt reduction. (Analysts’ price target is $30.80)
BUY ON WEAKNESS

MFC vs. RY MFC shows a nice uptrend, but facing long-term resistance. It's overbought, so enter around $26 during a sell-off. RY's chart is moderately positive with short-term resistance around $110. Not much upside at the current $107. Enter at $102-103.

BUY
Why is this trading at $27 when it should be over $30? MFC is transitioning. Insurance is a very long-tail businesses with products that need a lot of time to pay off (insurance policies). Their wealth management business in Asia is strong. It's been a long haul for MFC, going back to the Great Recession, and have been making slow progress. They are growing their book value. If things continue, they will grow their earnings and generally improve. She's happy to hold it. They're quarterly results are becoming consistent which will drive the stock. Pays a 3.6% yield.
DON'T BUY
Not a quality growth company. MFC is too hard for him to figure out. He'd rather buy a Canadian or American bank like National Bank.
BUY

MFC vs. SLF When he values lifecos, it's on price to book, dividend yield, or price to earnings, rather than price to cash flows. Sun Life trades at a premium. His preferred lifeco is Manulife, because of a discounted valuation plus a better business overall because of its Asian business. Wealth management is also better, and getting a handle on legacy businesses.

TOP PICK

It hit a 52 week high yesterday. There is potential for a resolution for some of their long term holdings. They are growing in Asia, where there are higher margins. It trades at a sizable valuation discount to its peers in the space. Yield 3.63% (Analysts’ price target is $30.33)

Showing 316 to 330 of 2,279 entries